Karyopharm Announces XPOVIO® (Selinexor) Clinical Data to be Presented at the American Society of Hematology 2019 Annual Meeting

NEXT STORY
U.S. Senate Passes Federal Anti-Cruelty Bill
PREV STORY
Aptose to Present New CG-806 Data at the 2019 ASH Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Tetra Bio-Pharma Convenes First National Medical Advisory Board

Key Opinion Leaders Weigh in on Scientific Research in CannabinoidsORLEANS, Ontario, Dec. 04, 2018 ...

author_avatar
NASDAQ Market News

Coherus BioSciences Completes Patent Dance Exchange with Amgen for Neulasta Biosimilar

REDWOOD CITY, Calif., April 25, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), announced ...

author_avatar
NASDAQ Market News

Aptose Provides Update on FDA Clinical Hold of APTO-253

SAN DIEGO and TORONTO, Oct. 13, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) ...

author_avatar
NASDAQ Market News